Lobbying

The Livingston Group, LLC Obo Innovative Vaccine Technologies's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q1 2024; the issues it reports most are Defense.

The Livingston Group, LLC Obo Innovative Vaccine Technologies

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q1 2024
The first quarter a report named it

Lobbying by quarter

The Livingston Group, LLC Obo Innovative Vaccine Technologies lobbying by quarter
The Livingston Group, LLC Obo Innovative Vaccine Technologies lobbying by quarter
QuarterAmountReports
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Defense$50K · 10 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE10 reports
  • Army, Dept of (Other)1 reports

Firms it paid

Firm
Oculus Strategies$50K10 quarters

Former officials lobbying for it

Former position
CHRISTOPHER CARONLD, Senior Policy Advisor, Deputy Chief of Staff, Rep. Tom Cole (OK-4)Q2 2026

Lobbying reports

Filed by
07/20for Q2Oculus StrategiesUnder $5,000
04/20for Q1Oculus StrategiesUnder $5,000
01/08for Q4 2025Oculus StrategiesUnder $5,000
25/10/07for Q3 2025Oculus StrategiesUnder $5,000
25/07/21for Q2 2025Oculus StrategiesUnder $5,000
25/04/24for Q1 2025Oculus Strategies$10K
25/01/21for Q4 2024Oculus Strategies$10K
24/10/21for Q3 2024Oculus Strategies$10K
24/07/26for Q2 2024Oculus Strategies$10K
24/04/21for Q1 2024Oculus Strategies$10K
24/03/14for Q1 2024Oculus StrategiesUnder $5,000